Precision Biosciences Inc. (DTIL) stock forecast and price target
Price $7.57 · data as of November 13, 2026
12-month price target
Average target$29.40
Upside / downside+288.6%
Analysts5
ConsensusStrong buy
Low $18.00Average $29.40High $60.00
Gold marker: average target · white marker: today’s price ($7.57)
Analyst ratings
Strong buy 0Buy 5Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-2.85 | +21.4% | $11M |
| Next fiscal year ends December 31, 2027 | $-2.19 | +23.1% | $9M |
| Next quarter ends December 31, 2026 | $-0.69 | −168.8% | $500000 |
| Quarter after ends March 31, 2027 | $-0.42 | +44.0% | $0 |
Consensus of the analysts covering Precision Biosciences, updated daily. In the last 30 days 0 estimates were raised and 3 lowered.
Frequently asked questions
What is the Precision Biosciences stock price target?
The average 12-month target from 5 analysts is $29.40, 288.6% above the current price of $7.57 Targets range from $18.00 to $60.00.
Is Precision Biosciences a buy according to analysts?
The consensus rating is “Strong buy” (5 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Precision Biosciences expected to earn?
Analysts expect EPS of $-2.85 for the fiscal year ending December 31, 2026 and $-2.19 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.